Who owns the PIONEERING CELL THERAPIES trademark?

The PIONEERING CELL THERAPIES trademark is owned by CellTrans Inc..

What class is the PIONEERING CELL THERAPIES trademark registered in?

The PIONEERING CELL THERAPIES trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for PIONEERING CELL THERAPIES?

The USPTO serial number for PIONEERING CELL THERAPIES is 87543744.

What is the registration number for PIONEERING CELL THERAPIES?

PIONEERING CELL THERAPIES is registered under USPTO registration number 5991584.

PIO

USPTO Trademark Record

REGISTERED

PIONEERING CELL THERAPIES

SN 87543744·Reg 5991584·Filed Jul 26, 2017

Owner CellTrans Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

PIONEERING CELL THERAPIES (Serial No. 87543744), Registration No. 5991584, is a registered US trademark filed on Jul 26, 2017 by CellTrans Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Section 8/9 declaration window: February 18, 2030

Mark Intelligence

PIONEERING CELL THERAPIES (Reg. #5991584) is a registered US trademark that has been protecting its owner, CellTrans Inc., since 2017. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 26, 2017

SERIAL

87543744

REG#

5991584

REGISTERED

Feb 18, 2020

Owner

Applicant

CellTrans Inc.

Entity

Corporation

State

Address

2201 W. Campbell Park Drive, Chicago, IL, 60612

Country

Attorney

Law firm

CellTrans Inc.

Address

2201 W. CAMPBELL PARK DRIVE, CHICAGO, IL 60612, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJul 26, 2017

Serial Number87543744

Registration No.5991584

Registration DateFeb 18, 2020

Status DateJun 20, 2026

Published for OppositionDec 25, 2018

Next RenewalFebruary 18, 2030

Mark TypeStandard characters

Status DescriptionLive and registered, Section 8 accepted

Filing Signals

FILED

2017

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: May 08, 2018

First use in commerce: Dec 03, 2019

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

29 events

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jun 20, 2026

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED

Jun 20, 2026

REGISTERED - SEC. 8 (6-YR) ACCEPTED

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Jun 20, 2026

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

TEAS SECTION 8 RECEIVED

Mar 09, 2026

TEAS SECTION 8 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Feb 18, 2025

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Feb 18, 2020

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 14, 2020

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Jan 13, 2020

STATEMENT OF USE PROCESSING COMPLETE

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 13, 2020

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 09, 2020

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Dec 30, 2019

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Dec 30, 2019

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 30, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 FILED

Jul 26, 2019

SOU EXTENSION 1 FILED

SOU TEAS EXTENSION RECEIVED

Jul 26, 2019

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 GRANTED

Jul 26, 2019

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 19, 2019

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Dec 25, 2018

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 25, 2018

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 05, 2018

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Nov 12, 2018

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 29, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Apr 27, 2018

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

ASSIGNED TO EXAMINER

Oct 26, 2017

ASSIGNED TO EXAMINER

SUSPENSION LETTER WRITTEN

Oct 26, 2017

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Oct 26, 2017

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Oct 26, 2017

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 31, 2017

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jul 29, 2017

NEW APPLICATION ENTERED

PIONEERING CELL THERAPIES

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks in Class 042 — Scientific, technology & SaaS services

Resources

Company